Report Published: "Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2015 Update"

From: Fast Market Research, Inc.
Published: Wed Sep 09 2015

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company, which undertakes the discovery and commercialization of molecular diagnostic tests, personalized medicine and services for major diseases. The company's product portfolio includes 13 commercial molecular diagnostic tests, including seven predictive medicine tests, three personalized medicine tests, two prognostic medicine tests and one diagnostic medicine test. By utilizing its multiplexed immunoassay technology also offers pharmaceutical and clinical services to pharmaceutical, biotechnology industries and medical research institutions. It markets its products through its own sales force in Europe and Canada and in through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

Full Report Details at

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Myriad Genetics, Inc.
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2015 Update
- Atlas Genetics Ltd. - Product Pipeline Analysis, 2015 Update
- Myriad Genetics, Inc. (MYGN) - Medical Equipment - Deals and Alliances Profile
- Oxford Gene Technology - Product Pipeline Analysis, 2015 Update
- Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2015 Update

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »